Herbas VPB

Print
EN | LT
LT - CRYSTALLINE FORM OF N-[(3-AMINO-3-OXETANYL)METHYL]-2-(2,3-DIHYDRO-1,1-DIOXIDO-1,4-BENZOTHIAZEPIN-4(5H)-YL)-6-METHYL-4-QUINAZOLINAMINE FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTIONS
EN - CRYSTALLINE FORM OF N-[(3-AMINO-3-OXETANYL)METHYL]-2-(2,3-DIHYDRO-1,1-DIOXIDO-1,4-BENZOTHIAZEPIN-4(5H)-YL)-6-METHYL-4-QUINAZOLINAMINE FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTIONS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 417/04
C07D 417/14
A61K 31/5415
A61P 31/12
A61P 31/14
European patent
(11) Number of the document 3322704
(13) Kind of document T
(96) European patent application number 16738155.7
Date of filing the European patent application 2016-07-12
(97) Date of publication of the European application 2018-05-23
(45) Date of publication and mention of the grant of the patent 2019-11-27
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/EP2016/066482
Date 2016-07-12
PCT application publication
(87) Number WO 2017/009316
Date 2017-01-19
Priority applications
(30) Number Date Country code
PCT/CN2015/0842 2015-07-16 WO
Inventors
(72)
ZHANG, Wei, CN
WANG, Lin, CN
LI, Wei, CN
Grantee
(73) F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel, CH
Title
(54) CRYSTALLINE FORM OF N-[(3-AMINO-3-OXETANYL)METHYL]-2-(2,3-DIHYDRO-1,1-DIOXIDO-1,4-BENZOTHIAZEPIN-4(5H)-YL)-6-METHYL-4-QUINAZOLINAMINE FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTIONS
  CRYSTALLINE FORM OF N-[(3-AMINO-3-OXETANYL)METHYL]-2-(2,3-DIHYDRO-1,1-DIOXIDO-1,4-BENZOTHIAZEPIN-4(5H)-YL)-6-METHYL-4-QUINAZOLINAMINE FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTIONS